These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20300631)

  • 1. A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.
    Koethe JR; Westfall AO; Luhanga DK; Clark GM; Goldman JD; Mulenga PL; Cantrell RA; Chi BH; Zulu I; Saag MS; Stringer JS
    PLoS One; 2010 Mar; 5(3):e9680. PubMed ID: 20300631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kericho CLinic-based ART Diagnostic Evaluation (CLADE): design, accrual, and baseline characteristics of a randomized controlled trial conducted in predominately rural, district-level, HIV clinics of Kenya.
    Sawe FK; Obiero E; Yegon P; Langat RC; Aoko A; Tarus J; Kiptoo I; Langat RK; Maswai J; Bii M; Khamadi S; Shikuku KP; Close N; Sinei S; Shaffer DN
    PLoS One; 2015; 10(2):e0116299. PubMed ID: 25706652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho.
    Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Namane T; Mpholo T; Battegay M; Klimkait T; Labhardt ND
    PLoS Med; 2020 Sep; 17(9):e1003325. PubMed ID: 32936795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varying intervals of antiretroviral medication dispensing to improve outcomes for HIV patients (The INTERVAL Study): study protocol for a randomized controlled trial.
    Hoffman R; Bardon A; Rosen S; Fox M; Kalua T; Xulu T; Taylor A; Sanne I
    Trials; 2017 Oct; 18(1):476. PubMed ID: 29029644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load.
    Kibalama Ssemambo P; Nalubega-Mboowa MG; Owora A; Serunjogi R; Kironde S; Nakabuye S; Ssozi F; Nannyonga M; Musoke P; Barlow-Mosha L
    BMC Pediatr; 2021 Mar; 21(1):139. PubMed ID: 33752636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of early initiation versus national standard of care of antiretroviral therapy in Swaziland's public sector health system: study protocol for a stepped-wedge randomized trial.
    Walsh FJ; Bärnighausen T; Delva W; Fleming Y; Khumalo G; Lejeune CL; Mazibuko S; Mlambo CK; Reis R; Spiegelman D; Zwane M; Okello V
    Trials; 2017 Aug; 18(1):383. PubMed ID: 28821264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.
    Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Achieng B; Sepeka M; Tlali K; Sao L; Thin K; Klimkait T; Battegay M; Labhardt ND
    BMC Infect Dis; 2018 Feb; 18(1):76. PubMed ID: 29433430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal test-and-treat in Zambian and South African correctional facilities: a multisite prospective cohort study.
    Herce ME; Hoffmann CJ; Fielding K; Topp SM; Hausler H; Chimoyi L; Smith HJ; Chetty-Makkan CM; Mukora R; Tlali M; Olivier AJ; Muyoyeta M; Reid SE; Charalambous S
    Lancet HIV; 2020 Dec; 7(12):e807-e816. PubMed ID: 32763152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings.
    Koller M; Fatti G; Chi BH; Keiser O; Hoffmann CJ; Wood R; Prozesky H; Stinson K; Giddy J; Mutevedzi P; Fox MP; Law M; Boulle A; Egger M
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):e110-9. PubMed ID: 26470034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine versus Targeted Viral Load Strategy among Patients Starting Antiretroviral in Hanoi, Vietnam.
    Pollack TM; Duong HT; Pham TT; Nguyen TD; Libman H; Ngo L; McMahon JH; Elliott JH; Do CD; Colby DJ
    J Int AIDS Soc; 2019 Mar; 22(3):e25258. PubMed ID: 30897303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection.
    Paton NI; Stöhr W; Oddershede L; Arenas-Pinto A; Walker S; Sculpher M; Dunn DT
    Health Technol Assess; 2016 Mar; 20(21):1-158. PubMed ID: 26986803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of point-of-care viral load monitoring in achieving the target of 90% suppression in HIV-infected patients in Nigeria: study protocol for a randomized controlled trial.
    Meloni ST; Agbaji O; Chang CA; Agaba P; Imade G; Oguche S; Mukhtar A; Mitruka K; Cox MH; Zee A; Kanki P
    BMC Infect Dis; 2019 May; 19(1):368. PubMed ID: 31046695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
    Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
    J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial.
    Gabagaya G; Rukundo G; Amone A; Wavamunno P; Namale-Matovu J; Lubega I; Nakabiito C; Namukwaya Z; Nolan M; Malamba SS; King R; Homsy J; Fowler MG; Musoke P
    BMC Infect Dis; 2021 Sep; 21(1):907. PubMed ID: 34481464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV treatment and monitoring patterns in routine practice: a multi-country retrospective chart review of patient care.
    Musa BM; Ibekwe E; Mwale S; Eurien D; Oldenburg C; Chung G; Heller RF
    F1000Res; 2018; 7():713. PubMed ID: 30647906
    [No Abstract]   [Full Text] [Related]  

  • 17. Care cascade structural intervention versus standard of care in the diagnosis and treatment of HIV in China: a cluster-randomized controlled trial protocol.
    Mao Y; Wu Z; McGoogan JM; Liu D; Gu D; Erinoff L; Ling W; VanVeldhuisen P; Detels R; Hasson AL; Lindblad R; Montaner JSG; Tang Z; Zhao Y
    BMC Health Serv Res; 2017 Jun; 17(1):397. PubMed ID: 28606085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: a retrospective cohort study.
    Sutcliffe CG; Bolton-Moore C; van Dijk JH; Cotham M; Tambatamba B; Moss WJ
    BMC Pediatr; 2010 Jul; 10():54. PubMed ID: 20673355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach.
    Sikazwe I; Eshun-Wilson I; Sikombe K; Czaicki N; Somwe P; Mody A; Simbeza S; Glidden DV; Chizema E; Mulenga LB; Padian N; Duncombe CJ; Bolton-Moore C; Beres LK; Holmes CB; Geng E
    PLoS Med; 2019 May; 16(5):e1002811. PubMed ID: 31150380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
    Nakalega R; Mukiza N; Kiwanuka G; Makanga-Kakumba R; Menge R; Kataike H; Maena J; Akello C; Atuhaire P; Matovu-Kiweewa F; Ndikuno-Kuteesa C; Debem H; Mujugira A
    BMC Infect Dis; 2020 Oct; 20(1):727. PubMed ID: 33023498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.